Retatrutide: GLP-1/GIP/Glucagon Triple Agonist Peptide
Retatrutide (LY3437943) is an investigational peptide developed by Eli Lilly that acts as a triple agonist at GLP-1, GIP, and glucagon receptors. It is currently under clinical investigation and is not approved for therapeutic use. ShiLai™ Healthcare supports Retatrutide manufacturing, formulation, and delivery system development for research and OEM programs.
Retatrutide Mechanism of Action
Retatrutide simultaneously activates three receptor pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This triple agonism is the subject of ongoing clinical research. All information on this page is based on published preclinical and clinical research data.
Retatrutide Manufacturing & OEM
ShiLai™ Healthcare manufactures Retatrutide in multiple delivery formats including lyophilized vials, single-chamber cartridges, dual-chamber cartridges, and prefilled injection pen systems. Each batch is supported by HPLC purity testing, LC-MS identity confirmation, and a Certificate of Analysis (COA).
Retatrutide Delivery Formats
Available formats include lyophilized vials, single-chamber prefilled cartridges, dual-chamber cartridges for reconstitution at point of use, and integrated pen + cartridge + packaging systems for OEM programs.
Research Use Disclaimer
Retatrutide is an investigational compound. It is not approved by any regulatory authority for clinical or therapeutic use. All products are manufactured and supplied for research purposes only. ShiLai™ Healthcare does not make therapeutic claims.
Frequently Asked Questions
What is Retatrutide?
Retatrutide (LY3437943) is an investigational triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, currently under clinical research by Eli Lilly.
What delivery formats does ShiLai™ Healthcare offer for Retatrutide?
ShiLai™ Healthcare offers Retatrutide in lyophilized vials, single-chamber cartridges, dual-chamber cartridges, and prefilled injection pen systems for OEM and research programs.
Does Retatrutide come with a COA?
Yes. All Retatrutide batches manufactured by ShiLai™ Healthcare are supported by a Certificate of Analysis (COA) including HPLC purity and LC-MS identity data.